~~<i id='69FE0FF07A'><strike id='69FE0FF07A'><tt id='69FE0FF07A'><pre id='69FE0FF07A'></pre></tt></strike></i>~~

00:00

00:00 00:00 LIVE

buffering

Replay

entertainment

explore

author：leisure time 2025-09-30 00:01:18 - browse：1

A green number 3 with an eye is surrounded by smaller, black number 3s on a purple background — 3 to watch coverage from STAT — Christine Kao/STAT

Life in the CRISPR lane tends to move at lightning speed. This year saw the first-ever approval of a medicine based on the gene editing technology, barely more than a decade after publication of its first demonstration by Nobel laureates Jennifer Doudna and Emmanuelle Charpentier.

The landmark decision paves the way for in vivo therapies, which edit cells inside the body, to reach patients, as well as treatments based on more efficient genome editors with fancier DNA-altering tricks up their sleeves.

Here are three CRISPR developments we’re watching in 2024:

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Indiana Supreme Court upholds abortion ban, says state constitution gives only limited protections
Next article： The Readout: Lenmeldy, GLP

focus

hotspot

focus

entertainment

focus

SuzanneKreiter/BostonGlobeTroubledhospitaloperatorStewardHealthCare,grapplingwithafinancialcrisistha

WSS

How state and local governments are sidelining science

NIH chief: government has fallen behind pharma on clinical trials

What health policies could hitch a ride on a spending bill?

Cancer diagnosis changes perspective doctor, former hospital CEO

Patient advocates debate FDA's accelerated approval process

Donor acceptance rates hint at racial, gender bias in heart transplants: study

entertainment

explore

focus

In Memoriam: Notable people who died in 2023

Merck drug for rare lung condition set for approval in U.S.

Bright Health sells Medicare Advantage business to Molina

Healthy food access boosts outcomes in two studies

New air purifier tech could be key to improving indoor air quality

Healthy food access boosts outcomes in two studies

At least 13 dead in Texas as scorching temps continue

States should stop sabotaging methadone treatment reform

Heart attack and stroke risk calculators need revising

Steward Health Care has deal to sell doctor network to UnitedHealth

hotspot

Readout LOUD Podcast: Lilly's obesity drug, the power of radiation

Healthy food access boosts outcomes in two studies

First transplant of an entire human eye performed

Abortion pill Supreme Court ruling could impact entire drug industry

Washington mulls new rules to avert another Change Healthcare

Readout Newsletter: Merck, Vertex, and Viking updates

focus

entertainment

focus

focus